Currently out of the existing stock ratings of Stan Berenshteyn, 19 are a BUY (35.19%), 5 are a SELL (9.26%), 30 are a HOLD (55.56%).

Stan Berenshteyn

Work Performance Price Targets & Ratings Chart

Analyst Stan Berenshteyn, currently employed at WELLS FARGO, carries an average stock price target met ratio of 71.12% that have a potential upside of 19.19% achieved within 153 days.

Stan Berenshteyn’s has documented 109 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DOCS, Doximity at 08-Nov-2024.

Wall Street Analyst Stan Berenshteyn

Analyst best performing recommendations are on AMWL (AMERICAN WELL CORP).
The best stock recommendation documented was for AMWL (AMERICAN WELL CORP) at 2/28/2022. The price target of $80 was fulfilled within 1 day with a profit of $4.6 (5.44%) receiving and performance score of 54.37.

Average potential price target upside

of $27.42 (41.26%) on HQY (HEALTHEQUITY).
of $23.14 (12.38%) on VEEV (VEEVA SYSTEMS).
of $5.83 (19.23%) on DOCS (DOXIMITY).

OMCL Omnicell ACCD Accolade GDRX Goodrx Holdings HQY HealthEquity DOCS Doximity HCAT Health Catalyst TDOC Teladoc VEEV Veeva Systems AMWL American Well Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matt Hewitt (CRAIG HALLUM)